Skip to main content
. 2017 Aug 24;8(48):84237–84247. doi: 10.18632/oncotarget.20494

Figure 2. Survival curves depicting DSS and DFS of BMSCC patients according to the expression levels of cleaved caspase-3 (CC-3) and caspase-3 (C-3).

Figure 2

HHS Vulnerability Disclosure